This invention relates to stabilizing adjacent vertebrae of the spine by inserting an intervertebral spacer, and more particularly an intervertebral spacer that is adjustable in height.
The vertebral or spinal column (spine, backbone) is a flexible assembly of vertebrae stacked on top of each other extending from the skull to the pelvic bone which acts to support the axial skeleton and to protect the spinal cord and nerves. The vertebrae are anatomically organized into four generalized body regions identified as cervical, thoracic, lumbar, and sacral; the cervical region including the top of the spine beginning in the skull, the thoracic region spanning the torso, the lumbar region spanning the lower back, and the sacral region including the base of the spine ending with connection to the pelvic bone. With the exception of the first two cervical vertebrae, cushion-like discs separate adjacent vertebrae, i.e. intervertebral discs.
The stability of the vertebral column during compression and movement is maintained by the intervertebral discs. Each disc includes a gel-like center surrounded by a fibrous ring. The gel-like center, i.e. nucleus pulposus, provides strength such that the disc can absorb and distribute external loads and contains a mixture of type II-collagen dispersed in a proteoglycan matrix. The fibrous ring, or annulus fibrosus, provides stability during motion and contains laminated rings of type-I collagen. Thus, the annulus fibrosis and the nucleus pulposus are interdependent, as the annulus fibrosis contains the nucleus pulposus in place and the nucleus pulposus aligns the annulus fibrosus to accept and distribute external loads. The integrity of the composition and structure of the intervertebral disc is necessary to maintain normal functioning of the intervertebral disc.
Many factors can adversely alter the composition and structure of the intervertebral disc, such as normal physiological aging, mechanical injury/trauma, and/or disease, resulting in impairment or loss of disc function. For example, the content of proteoglycan n the nucleus pulposus declines with age, thus, it follows that the ability of the nucleus pulposus to absorb water concurrently declines. Therefore, in normal aging the disc progressively dehydrates, resulting in a decrease in disc height and possible de-lamination of the annulus fibrosus. Mechanical injury can tear the annulus fibrosis allowing the gel-like material of the nucleus pulposus to extrude into the spinal canal and compress neural elements. Growth of a spinal tumor can impinge upon the vertebrae and/or disc potentially compressing nerves.
Bones of the spine, and bony structures, generally, are susceptible to a variety of weaknesses that can affect their ability to provide support and structure. Weaknesses in bony structures have numerous potential causes, including degenerative diseases, tumors, fractures, and dislocations. Advances in medicine and engineering have provided doctors with a plurality of devices and techniques for alleviating or curing these weaknesses.
In some cases, the spinal column, in particular, requires additional support in order to address such weaknesses. One technique for providing support is to insert a spacer between adjacent vertebrae.
In accordance with an embodiment of the disclosure, a spacer for separating bone of a joint may be provided, wherein the spacer may comprise: a first endplate configured to engage a first bone of the joint; a second endplate configured to engage a second bone of the joint; and an actuation subassembly comprising a drive nut, a drive screw coupled to the drive nut, and a cam frame coupled to the drive screw, wherein the cam frame is disposed between the first endplate and the second endplate, wherein the cam frame comprises a proximal frame end, a distal frame end, and lateral frame sides, wherein cams disposed on the lateral frame sides selectively engage at least one of the first endplate or the second endplate.
In accordance with an embodiment of the disclosure, a method of separating bones of a joint may be provided, wherein the method may comprise inserting a spacer between bones of the joint; and translating a cam frame along a longitudinal axis of the spacer, wherein cams disposed on the cam frame engage at least one of a first endplate and/or a second endplate increasing a height of the spacer.
These drawings illustrate certain aspects of some examples of the present invention, and should not be used to limit or define the invention.
Embodiments are directed to a spacer that may be inserted between two adjacent bony surfaces to facilitate separation of the bones, and if desired, to promote the fusion of bony surfaces. Although intended to be useful with any adjacent bony surface in which fusion is desired, the spacer may advantageously be applied to insertion between two adjacent vertebral bodies in any section of the spine, including the cervical, thoracic, lumbar, and sacral vertebral sections. Additionally, the spacer may be implanted through an anterior, anterolateral, posterior, posterolateral, lateral, or any other suitable approach. More than one spacer may be implanted within the body, for example between successive or separated vertebrae, between adjacent vertebrae. The use of multiple spacers is particularly advantageous for patients whose back pain is not limited to a localized area, or for patients whose localized damage has progressed to other areas of the spine.
The spacer and methods for its insertion can be used in a treatment protocol for any of a wide variety of conditions in a patient involving diseased or damaged bony structures. The patient can be a human being. Additionally, it is contemplated that the spacer may be useful in veterinary science for any animal having adjacent bony structures to be fused. The spacer can collapse, for example, to approximately one half of an expanded size. When in this collapsed configuration, the spacer can be inserted into a space through a small incision and narrow pathways, using appropriate minimally-invasive techniques, and can be positioned within the space between adjacent bones, and there expanded to a desired therapeutic height. The incision may be short, for example about one inch in length, which is smaller than the spacer in an expanded configuration. If the desired position and/or expansion are not achieved, the spacer can be collapsed, repositioned, and re-expanded in situ.
Although the spacer is exemplified herein for use in the spine, the spacer is contemplated for fusion of any bony structures. While the spacers are described herein using several varying embodiments, the spacers are not limited to these embodiments. An element of one embodiment may be used in another embodiment, or an embodiment may not include all described elements.
With reference now to
Spacer 100 forms a distal end 106 which may be inserted first into the body, and which can be tapered to facilitate insertion between body tissues. Spacer 100 also forms a proximal end 108, to which a spacer insertion device (e.g. 202 shown on
Turning now to
In some embodiments, endplates 102 may further comprise through openings 136. Through openings 136 may form an opening in endplates 102 that extends from outer facing surface 122 to inner facing surface 126. The through opening 136, in an exemplary embodiment, may be sized to receive bone graft or similar bone growth inducing material and further allow the bone graft or similar bone growth inducing material to be packed in a central opening 138 in cam frame 112 (best seen on
With specific reference to
As seen in
Endplates 102 may additionally, or alternatively, be resilient, so that they may conform to bony surfaces, forming a more stable support platform. Accordingly, endplates 102 can be fabricated from a polymeric material, a naturally resilient material, or a resilient metal, for example a shape memory alloy, or any other resilient biocompatible material of sufficient strength and durability for separating bones within the body.
Turning now to
In some embodiments, cam slots 160 may be formed in lateral frame sides 152. As illustrated three cam slots 160 may be formed in each of lateral frame sides 152. However, it should be understood that more or less than three cam slots 160 may be used. The number of cam slots 160 generally may correspond to the number of cam pins 114. At least a portion of cam pins 114 may be disposed in a corresponding one of cam slots 160. By way of example, each of cam pins 114 may include a protuberance, such as ridge 162 (best seen on
Turning now to
Front plate 174 of spacer 100 is shown in more detail on
As illustrated, actuation subassembly 104 may comprise cam frame 112, drive screw 132, and drive nut 113. Cam frame 112 may be displaced relative to endplates 102 by rotation of drive nut 113 which in turn moves drive screw 132 and cam frame 112 along spacer longitudinal axis 110. In some embodiments, rotation of drive nut 113 may cause cam frame 112 to translate a path along spacer longitudinal axis 110. A spacer insertion device (e.g., 202 on
Embodiments of drive nut 113 may also include a nut through bore 188, which may be threaded as best seen on
In some embodiments, drive screw 132 may be secured in drive nut 113 at one end and be secured to cam frame 112 at another end. Drive screw 132 may include a retainer groove 200, best seen on
Referring now to
Referring now to
Embodiments of spacer 100, and its various components, shown on
Referring now to
With reference to
As best on
Referring now to
In some embodiments, spacer 100 may be fabricated using any biocompatible materials known or hereinafter discovered, having sufficient strength, flexibility, resiliency, and durability for the patient, and for the term during which the device is to be implanted. Examples include but are not limited to metal, such as, for example titanium and chromium alloys; stainless steel, polymers, including for example, PEEK or high molecular weight polyethylene (HMWPE); and ceramics. There are many other biocompatible materials which may be used, including other plastics and metals, as well as fabrication using living or preserved tissue, including autograft, allograft, and xenograft material. Portions or all of the spacer 100 may be radiopaque or radiolucent, or materials having such properties may be added or incorporated into the spacer 100 to improve imaging of the device during and after implantation. Any surface or component of a spacer 100 may be coated with or impregnated with therapeutic agents, including bone growth, healing, antimicrobial, or drug materials, which may be released at a therapeutic rate, using methods known to those skilled in the art.
In some embodiments, spacer 100 may be formed using titanium, or a cobalt-chrome-molybdenum alloy, Co—Cr—Mo, for example as specified in ASTM F1537 (and ISO 5832-12). The smooth surfaces may be plasma sprayed with commercially pure titanium, as specified in ASTM F1580, F1978, F1147 and C-633 (and ISO 5832-2). Alternatively, part or all of spacers 100 may be formed with a polymer, for example ultra-high molecular weight polyethylene, UHMWPE, for example as specified in ASTM F648 (and ISO 5834-2). In one embodiment, PEEK-OPTIMA (a trademark of Invibio Ltd Corp, United Kingdom) may be used for one or more components of the disclosed spacers 100. For example, polymeric portions can be formed with PEEK-OPTIMA, which is radiolucent, whereby bony ingrowth may be observed. Other polymeric materials with suitable flexibility, durability, and biocompatibility may also be used.
In accordance with present embodiments, spacer 100 may be provided in various sizes to best fit the anatomy of the patient. Components of matching or divergent sizes may be assembled during the implantation procedure by a medical practitioner as best meets the therapeutic needs of the patient, the assembly inserted within the body using an insertion tool. In some embodiments, spacer 100 may also be provided with an overall angular geometry, for example an angular mating disposition of endplates, to provide for a natural lordosis, or a corrective lordosis, for example of from 0° to 12° for a cervical application, although much different values may be advantageous for other joints. Lordotic angles may also be formed by shaping one or both endplates to have relatively non-coplanar surfaces.
In some embodiments, a single spacer 100 may be used, to provide stabilization for a weakened joint or joint portion. Alternatively, a combination of two, three, or more of any of spacer 100 may be used, at a single joint level, or in multiple joints. Moreover, implants of the disclosure may be combined with other stabilizing means.
In some embodiments, a spacer 100 may be fabricated using material that biodegrades in the body during a therapeutically advantageous time interval, for example after sufficient bone ingrowth has taken place. Further, implants of the disclosure are advantageously provided with smooth and or rounded exterior surfaces, which reduce a potential for deleterious mechanical effects on neighboring tissues.
In some embodiments, a spacer 100 may be provided to be support adjacent vertebrae during flexion/extension, lateral bending, and axial rotation. In one embodiment, spacer 100 is indicated for spinal arthroplasty in treating skeletally mature patients with degenerative disc disease, primary or recurrent disc herniation, spinal stenosis, or spondylosis in the lumbosacral spine (LI-SI). The surgery to implant spacer 100 may be performed through an Anterior, Anterolateral, Posterolateral, Lateral, or any other approach.
The terms “a” or “an”, as used herein, are defined as one or more than one. The term plurality, as used herein, is defined as two or more than two. The term another, as used herein, is defined as at least a second or more. The terms “including” and “having,” as used herein, are defined as comprising (i.e., open language).
Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations may be made herein without departing from the spirit and scope of the invention as defined by the appended claims
This application is a continuation of U.S. patent application Ser. No. 16/453,038, filed on Jun. 26, 2109, which is a divisional of U.S. patent application Ser. No. 14/970,598, filed Dec. 16, 2015, 2015, which is incorporated by reference herein in its entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4349921 | Kuntz | Sep 1982 | A |
4599086 | Doty | Jul 1986 | A |
4863476 | Sheppherd | Sep 1989 | A |
4863477 | Monson | Sep 1989 | A |
5123926 | Pisharodi | Jun 1992 | A |
5290312 | Kojimoto et al. | Mar 1994 | A |
5306310 | Siebels | Apr 1994 | A |
5375823 | Navas | Dec 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5522899 | Michelson | Jun 1996 | A |
5534030 | Navarro et al. | Jul 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5571192 | Schonhoffer | Nov 1996 | A |
5645596 | Kim et al. | Jul 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5676701 | Yuan et al. | Oct 1997 | A |
6039761 | Li et al. | Mar 2000 | A |
6045579 | Hochschuler et al. | Apr 2000 | A |
6080193 | Hochschuler et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6126689 | Brett | Oct 2000 | A |
6176882 | Biedermann | Jan 2001 | B1 |
6258125 | Paul et al. | Jul 2001 | B1 |
6554863 | Paul et al. | Apr 2003 | B2 |
6558423 | Michelson | May 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6576016 | Hochshuler et al. | Jun 2003 | B1 |
6641614 | Wagner et al. | Nov 2003 | B1 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
6692495 | Zacouto | Feb 2004 | B1 |
6706070 | Wagner et al. | Mar 2004 | B1 |
6752832 | Ulrich | Jun 2004 | B2 |
6814756 | Michelson | Nov 2004 | B1 |
6830589 | Erickson | Dec 2004 | B2 |
6849093 | Michelson | Feb 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6881228 | Zdeblick et al. | Apr 2005 | B2 |
7018415 | McKay | Mar 2006 | B1 |
7070598 | Lim et al. | Jul 2006 | B2 |
7204853 | Gordon | Apr 2007 | B2 |
7217291 | Zucherman et al. | May 2007 | B2 |
7282063 | Cohen et al. | Oct 2007 | B2 |
7316714 | Gordon | Jan 2008 | B2 |
7473276 | Aebi | Jan 2009 | B2 |
7547325 | Biedermann | Jun 2009 | B2 |
7621953 | Braddock, Jr. et al. | Nov 2009 | B2 |
7641693 | Gutlin et al. | Jan 2010 | B2 |
7682396 | Beaurain et al. | Mar 2010 | B2 |
7749270 | Peterman | Jul 2010 | B2 |
7753958 | Gordon | Jul 2010 | B2 |
7771473 | Thramann | Aug 2010 | B2 |
7780732 | Abernathie | Aug 2010 | B2 |
7799081 | McKinley | Sep 2010 | B2 |
7815683 | Melkent et al. | Oct 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7875078 | Wysocki et al. | Jan 2011 | B2 |
7901409 | Canaveral et al. | Mar 2011 | B2 |
7909869 | Gordon | Mar 2011 | B2 |
7951199 | Miller | May 2011 | B2 |
7985256 | Grotz et al. | Jul 2011 | B2 |
8062375 | Glerum | Nov 2011 | B2 |
8070813 | Grotz et al. | Dec 2011 | B2 |
8105382 | Olmos et al. | Jan 2012 | B2 |
8123810 | Gordon | Feb 2012 | B2 |
8137405 | Kostuik et al. | Mar 2012 | B2 |
8192495 | Simpson et al. | Jun 2012 | B2 |
8303663 | Jimenez et al. | Nov 2012 | B2 |
8377140 | DeFalco et al. | Feb 2013 | B2 |
8394129 | Lopez et al. | Mar 2013 | B2 |
8394143 | Grotz et al. | Mar 2013 | B2 |
8435296 | Kadaba et al. | May 2013 | B2 |
8454695 | Grotz et al. | Jun 2013 | B2 |
8647386 | Gordon | Feb 2014 | B2 |
8696751 | Ashley et al. | Apr 2014 | B2 |
8771360 | Jimenez et al. | Jul 2014 | B2 |
8894710 | Simpson et al. | Nov 2014 | B2 |
8932355 | Grotz et al. | Jan 2015 | B2 |
8940049 | JImenez et al. | Jan 2015 | B1 |
8956413 | Ashley et al. | Feb 2015 | B2 |
8992620 | Ashley et al. | Mar 2015 | B2 |
9028550 | Shulock et al. | May 2015 | B2 |
9358125 | JImenez et al. | Jun 2016 | B2 |
9532883 | McLuen et al. | Jan 2017 | B2 |
9622878 | Grotz | Apr 2017 | B2 |
20020045945 | Liu | Apr 2002 | A1 |
20020068976 | Jackson | Jun 2002 | A1 |
20020068977 | Jackson | Jun 2002 | A1 |
20030176926 | Boehm et al. | Sep 2003 | A1 |
20040030387 | Landry et al. | Feb 2004 | A1 |
20040049271 | Biedermann et al. | Mar 2004 | A1 |
20040054412 | Gerbec et al. | Mar 2004 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040153065 | Lim | Aug 2004 | A1 |
20050021041 | Michelson | Jan 2005 | A1 |
20050021145 | de Villiers et al. | Jan 2005 | A1 |
20050033432 | Gordon | Feb 2005 | A1 |
20050080422 | Otte et al. | Apr 2005 | A1 |
20050113916 | Branch | May 2005 | A1 |
20050149188 | Cook et al. | Jul 2005 | A1 |
20050171541 | Boehm | Aug 2005 | A1 |
20050251258 | Jackson | Nov 2005 | A1 |
20050273171 | Gordon | Dec 2005 | A1 |
20050273174 | Gordon | Dec 2005 | A1 |
20050278026 | Gordon | Dec 2005 | A1 |
20050283244 | Gordon | Dec 2005 | A1 |
20050283245 | Gordon | Dec 2005 | A1 |
20060004453 | Bartish, Jr. et al. | Jan 2006 | A1 |
20060015184 | Winterbottom et al. | Jan 2006 | A1 |
20060058878 | Michelson | Mar 2006 | A1 |
20060084986 | Grinberg et al. | Apr 2006 | A1 |
20060122701 | Kister | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060142859 | Mcluen | Jun 2006 | A1 |
20060149385 | Mckay | Jul 2006 | A1 |
20060195192 | Gordon et al. | Aug 2006 | A1 |
20060229729 | Gordon | Oct 2006 | A1 |
20060241770 | Rhoda et al. | Oct 2006 | A1 |
20060253201 | Mcluen | Nov 2006 | A1 |
20070043442 | Abernathie | Feb 2007 | A1 |
20070050030 | Kim | Mar 2007 | A1 |
20070050032 | Gittings et al. | Mar 2007 | A1 |
20070055377 | Hanson et al. | Mar 2007 | A1 |
20070191951 | Branch | Aug 2007 | A1 |
20070250168 | Lechmann et al. | Oct 2007 | A1 |
20070255415 | Edie et al. | Nov 2007 | A1 |
20070270963 | Melkent et al. | Nov 2007 | A1 |
20070270968 | Baynham | Nov 2007 | A1 |
20080021559 | Thramann | Jan 2008 | A1 |
20080065222 | Hamada | Mar 2008 | A1 |
20080114467 | Capote et al. | May 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20080147194 | Grotz et al. | Jun 2008 | A1 |
20080161933 | Grotz et al. | Jul 2008 | A1 |
20080167657 | Greenhalgh | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080221694 | Warnick et al. | Sep 2008 | A1 |
20080275455 | Berry et al. | Nov 2008 | A1 |
20080281346 | Greenhalgh et al. | Nov 2008 | A1 |
20080288073 | Renganath et al. | Nov 2008 | A1 |
20080300598 | Barriero et al. | Dec 2008 | A1 |
20080306488 | Altarac et al. | Dec 2008 | A1 |
20080319487 | Fielding et al. | Dec 2008 | A1 |
20080319549 | Greenhalgh et al. | Dec 2008 | A1 |
20090024217 | Levy et al. | Jan 2009 | A1 |
20090062833 | Song | Mar 2009 | A1 |
20090076616 | Duggal et al. | Mar 2009 | A1 |
20090125062 | Arnin | May 2009 | A1 |
20090149956 | Greenhalgh et al. | Jun 2009 | A1 |
20090149959 | Conner et al. | Jun 2009 | A1 |
20090204218 | Richelsoph | Aug 2009 | A1 |
20090222100 | Cipoletti et al. | Sep 2009 | A1 |
20090240334 | Richelsoph | Sep 2009 | A1 |
20090270989 | Conner et al. | Oct 2009 | A1 |
20090281628 | Oglaza et al. | Nov 2009 | A1 |
20090292361 | Lopez | Nov 2009 | A1 |
20090299478 | Carls et al. | Dec 2009 | A1 |
20090312763 | McCormack | Dec 2009 | A1 |
20100049324 | Valdevit | Feb 2010 | A1 |
20100070041 | Peterman | Mar 2010 | A1 |
20100082109 | Greenhalgh et al. | Apr 2010 | A1 |
20100145455 | Simpson et al. | Jun 2010 | A1 |
20100179657 | Greenhalgh et al. | Jul 2010 | A1 |
20100185291 | Jimenez | Jul 2010 | A1 |
20100191336 | Greenhalgh | Jul 2010 | A1 |
20100204795 | Greenhalgh | Aug 2010 | A1 |
20100211176 | Greenhalgh | Aug 2010 | A1 |
20100222816 | Gabelberger et al. | Sep 2010 | A1 |
20100222884 | Greenhalgh | Sep 2010 | A1 |
20100234952 | Peterman | Sep 2010 | A1 |
20100249933 | Trieu | Sep 2010 | A1 |
20100280622 | Mckinley | Nov 2010 | A1 |
20100286779 | Thibodeau | Nov 2010 | A1 |
20100286780 | Dryer | Nov 2010 | A1 |
20100286783 | Lechmann et al. | Nov 2010 | A1 |
20100292796 | Greenhalgh et al. | Nov 2010 | A1 |
20100305705 | Butler | Dec 2010 | A1 |
20100331981 | Mohammed | Dec 2010 | A1 |
20100331985 | Gordon | Dec 2010 | A1 |
20110035011 | Cain | Feb 2011 | A1 |
20110093074 | Glerum et al. | Apr 2011 | A1 |
20110160861 | Jimenez et al. | Jun 2011 | A1 |
20110172774 | Varela | Jul 2011 | A1 |
20110184522 | Melkent et al. | Jul 2011 | A1 |
20110276142 | Niemiec et al. | Nov 2011 | A1 |
20110301713 | Theofilos | Dec 2011 | A1 |
20110319997 | Glerum et al. | Dec 2011 | A1 |
20120035729 | Glerum et al. | Feb 2012 | A1 |
20120059470 | Weiman | Mar 2012 | A1 |
20120059472 | Weiman | Mar 2012 | A1 |
20120109308 | Lechmann et al. | May 2012 | A1 |
20120130496 | Duffield et al. | May 2012 | A1 |
20120165945 | Hansell et al. | Jun 2012 | A1 |
20120185049 | Varela | Jul 2012 | A1 |
20120209386 | Triplett et al. | Aug 2012 | A1 |
20120215313 | Saidha et al. | Aug 2012 | A1 |
20120226357 | Varela | Sep 2012 | A1 |
20120265309 | Glerum et al. | Oct 2012 | A1 |
20120277861 | Steele et al. | Nov 2012 | A1 |
20120277870 | Wolters et al. | Nov 2012 | A1 |
20120323329 | Jimenez et al. | Dec 2012 | A1 |
20120330426 | McLaughlin et al. | Dec 2012 | A1 |
20130023993 | Weiman | Jan 2013 | A1 |
20130023994 | Glerum | Jan 2013 | A1 |
20130158663 | Miller et al. | Jun 2013 | A1 |
20130158669 | Sungarian et al. | Jun 2013 | A1 |
20130197647 | Wolters et al. | Aug 2013 | A1 |
20130211526 | Alheidt et al. | Aug 2013 | A1 |
20130274883 | McLuen et al. | Oct 2013 | A1 |
20140067071 | Weiman et al. | Mar 2014 | A1 |
20140088714 | Miller et al. | Mar 2014 | A1 |
20140163683 | Seifert et al. | Jun 2014 | A1 |
20150066145 | Rogers et al. | Mar 2015 | A1 |
20150088258 | Jimenez et al. | Mar 2015 | A1 |
20150134064 | Grotz et al. | May 2015 | A1 |
20150216676 | Shulock et al. | Aug 2015 | A1 |
20150289988 | Ashley et al. | Oct 2015 | A1 |
20150374508 | Sandul | Dec 2015 | A1 |
20160166396 | McClintock | Jun 2016 | A1 |
20160324654 | Loebl et al. | Nov 2016 | A1 |
20170100258 | Jimenez et al. | Apr 2017 | A1 |
20170119543 | Dietzel et al. | May 2017 | A1 |
Number | Date | Country |
---|---|---|
2088066 | Jan 1992 | CA |
4012622 | Jul 1991 | DE |
4327054 | Apr 1995 | DE |
0576379 | Jun 1993 | EP |
0610837 | Jul 1994 | EP |
3111896 | Jan 2017 | EP |
2794968 | Dec 2000 | FR |
2794968 | Dec 2000 | FR |
2874814 | Mar 2006 | FR |
2000-513263 | Oct 2000 | JP |
2000-513263 | Oct 2000 | JP |
2000513263 | Oct 2000 | JP |
2013508031 | Mar 2013 | JP |
200290058 | Sep 2002 | KR |
1424826 | Sep 1988 | SU |
9201428 | Feb 1992 | WO |
9525485 | Sep 1995 | WO |
199942062 | Aug 1999 | WO |
1999042062 | Aug 1999 | WO |
199966867 | Dec 1999 | WO |
1999066867 | Dec 1999 | WO |
2002045625 | Jun 2002 | WO |
2004019829 | Mar 2004 | WO |
2004069033 | Aug 2004 | WO |
2006045094 | Apr 2006 | WO |
WO2006045094 | Apr 2006 | WO |
2006047587 | May 2006 | WO |
2006113080 | Oct 2006 | WO |
WO2006113080 | Oct 2006 | WO |
2008044057 | Apr 2008 | WO |
WO2008044057 | Apr 2008 | WO |
2008134515 | Nov 2008 | WO |
2009114381 | Sep 2009 | WO |
2010103344 | Sep 2010 | WO |
2012031267 | Mar 2012 | WO |
2015009793 | Jan 2015 | WO |
Number | Date | Country | |
---|---|---|---|
20210322182 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14970598 | Dec 2015 | US |
Child | 16453038 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16453038 | Jun 2019 | US |
Child | 17365219 | US |